Crossmark

Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside

Crossref DOI link: https://doi.org/10.1007/s00109-017-1564-y

Published Online: 2017-07-10

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Garić, Dušan

De Sanctis, Juan B.

Wojewodka, Gabriella

Houle, Daniel

Cupri, Shanon

Abu-Arish, Asmahan

Hanrahan, John W.

Hajduch, Marian

Matouk, Elias

Radzioch, Danuta https://orcid.org/0000-0002-1601-2757
Funding

Funding for this research was provided by:

Ministère du Développement Économique, de l'Innovationet de l'Exportation (MDEIE/MESRST)

Fondo Nacional de Ciencia Tecnología e Innovación (G2005000389)

Ministère du Développement Économique, de l'Innovationet de l'Exportation (MDEIE/MESRST) (Ministère du Développement Économique, de l'Innovationet de l'Exportation (MDEIE/MESRST))

Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award

Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada

Cystic Fibrosis Canada

Groupe de Recherche Axé sur la Structure des Protéins (GRASP)

Canadian Institutes of Health Research

Cystic Fibrosis Foundation
License Information

License valid from 2017-07-10